Back to Screener

Healthcare

Standard BioTools Inc.(LAB)

Live Price

Offline

$0.73

-1.35% today

1Y Change

-38.32%

Window

Jun 30, 2025 โ†’ Jun 25, 2026

Market Cap
$360.00M
Revenue Growth
-51.1%
EPS Growth
+61.5%
Dividend Yield
0.0%

Coverage: 248 bars ยท Jun 30, 2025 โ†’ Jun 25, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Standard BioTools Inc. (LAB) is a Healthcare stock with a market cap of $360.00M and listed on NASDAQ. The stock last traded around $0.73 and down 38.3% across the available one-year price window (Jun 30, 2025 โ†’ Jun 25, 2026). Baseline metrics include revenue growth of -51.1%, EPS growth of +61.5%, a dividend yield of 0.0%. What stands out right now is revenue -51.1%, EPS +61.5%, free cash flow +45.6% with operating margin -109.3% and ROIC -12.2%. Valuation sits in the middle of the pack at price/sales 4.3. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines LAB price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

LAB vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

Relative Read

LAB trails SPY

LAB is 57.17 pts behind over the shared 1Y window.

LAB had 46.81 pts deeper max drawdown than SPY.

LAB beat SPY in 0 of 2 calendar years shown and trailed in 2.

LAB

-38.32%

Normalized return

SPY

+18.85%

S&P 500

Excess Return

-57.17 pts

Relative to SPY

LAB Max Drawdown

-55.95%

Trailing 1Y

SPY Max Drawdown

-9.13%

Trailing 1Y

LABSPY

Calendar-Year Returns

Uses the longest available daily history for LAB and SPY.

YearLABSPYExcessLeader
2026-41.72%+6.71%-48.43 ptsSPY
2025+4.17%+11.19%-7.03 ptsSPY

Earnings Reports

๐Ÿ“… Last reportedMay 5, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
Feb 24, 26
โœ“
0.06
Est -0.03
+300.0%
23.8M
Est 18.5M
+28.6%
Feb 24
โ€”
Nov 4, 25
โœ—
-0.04
Est -0.03
-60.0%
19.6M
Est 18.5M
+5.7%
Nov 4
โ€”
Aug 11, 25
โ€”
-0.04
Est -0.04
0.0%
21.8M
Est 40.9M
-46.8%
Aug 11
โ€”
May 6, 25
โ€”
-0.04
Est -0.04
0.0%
40.8M
Est 39.2M
+4.0%
May 6
โ€”
Feb 26, 25
โœ“
-0.05
Est -0.07
+28.6%
46.7M
Est 43.0M
+8.6%
Feb 26
โ€”
Oct 30, 24
โœ“
-0.05
Est -0.08
+37.5%
45.0M
Est 43.0M
+4.5%
Oct 30
โ€”
Jul 31, 24
โœ—
-0.08
Est -0.06
-33.3%
37.2M
Est 41.3M
-9.9%
Jul 31
โ€”
May 8, 24
โœ—
-0.23
Est -0.09
-155.6%
45.5M
Est 46.0M
-1.0%
May 8
โ€”
Feb 28, 24
โœ“
-0.08
Est -0.13
+38.5%
28.2M
Est 24.9M
+13.2%
Feb 28
โ€”
Nov 7, 23
โœ—
-0.15
Est -0.12
-25.0%
25.4M
Est 23.6M
+7.5%
Nov 7
โ€”
Aug 8, 23
โœ“
-0.14
Est -0.21
+33.3%
27.7M
Est 24.2M
+14.3%
Aug 8
โ€”
May 9, 23
โœ—
-0.11
Est -0.06
-98.8%
25.1M
Est 28.4M
-11.4%
May 9
โ€”
Feb 14, 23
โœ—
-0.19
Est -0.11
-72.7%
27.0M
Est 38.0M
-28.9%
Feb 14
โ€”
Nov 8, 22
โœ—
-0.26
Est -0.13
-100.0%
25.6M
Est 30.9M
-17.1%
Nov 8
โ€”
Aug 8, 22
โœ—
-0.33
Est -0.13
-153.8%
18.8M
Est 29.8M
-37.0%
Aug 8
โ€”
May 5, 22
โœ—
-0.25
Est -0.15
-66.7%
26.5M
Est 25.6M
+3.3%
May 5
โ€”
Feb 17, 22
โœ“
-0.12
Est -0.28
+57.1%
38.3M
Est 32.7M
+17.1%
Feb 17
โ€”
Nov 8, 21
โœ“
-0.18
Est -0.22
+18.2%
28.5M
Est โ€”
โ€”
Nov 8
โ€”
Aug 5, 21
โœ—
-0.23
Est -0.19
-21.1%
31.0M
Est โ€”
โ€”
Aug 5
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the market calendar